Physician profile
David E Hamming
NPI 1609068386
$1,395.37
in general payments reported to CMS, 2019-2025
16 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.82 · 2020: $316 · 2021: $474 · 2022: $219 · 2023: $68.33 · 2024: $122 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $692.67 | 2019-2021 | |
| Radius Health, INC. | $126.86 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $102.42 | 2024-2025 | Exparel, Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $100.55 | 2023-2025 | Euflexxa |
| Vericel Corporation | $63.57 | 2024-2025 | Maci |
| Orthofix Medical, INC. | $53.16 | 2023-2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $50.21 | 2022 | |
| Abbott Laboratories | $43.23 | 2021-2022 | |
| Stryker Corporation | $25.12 | 2021 | |
| Organogenesis INC. | $23.46 | 2023 | Puraply |
| Amgen INC. | $23.24 | 2020 | |
| Boston Scientific Corporation | $22.28 | 2021 | |
| Sanara Medtech INC. | $20.80 | 2020 | |
| Heraeus Medical, LLC. | $20.78 | 2022 | |
| Kci USA, INC. | $13.71 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hamming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.